Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 43 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B11,10-phenanthroline - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B14-(((1-hydroxynaphthalen-2-yl)(phenyl)methyl)amino)benzoic acid inhibitor causes a reduction in Rce1 in vitro activity, exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in human colon carcinoma cells. FTase activity is not inhibited at concentrations as high as 50 microM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B14-(((4-bromo-2,6-difluorophenyl)(1-hydroxynaphthalen-2-yl)methyl)amino)benzoic acid inhibitor causes a reduction in Rce1 in vitro activity, exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in human colon carcinoma cells. FTase activity is not inhibited at concentrations as high as 50 microM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B14-(((4-bromophenyl)(1-hydroxynaphthalen-2-yl)methyl)amino)benzoic acid inhibitor causes a reduction in Rce1 in vitro activity, exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in human colon carcinoma cells. FTase activity is not inhibited at concentrations as high as 50 microM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B14-(((4-bromophenyl)(8-hydroxyquinolin-7-yl)methyl)amino)benzoate inhibitor causes a reduction in Rce1 in vitro activity, exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in human colon carcinoma cells. FTase activity is not inhibited at concentrations as high as 50 microM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B14-(((8-hydroxyquinolin-7-yl)(phenyl)methyl)amino)benzoate inhibitor causes a reduction in Rce1 in vitro activity, exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in human colon carcinoma cells Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B1benzyloxycarbonyl-Phe-Ala-2,4,6-trimethylbenzoyloxymethyl ketone 0.25 mM, 8% inhibition of cleavage of a quenched fluorogenic farnesylated peptide that is based on the C-terminal sequence of the K-Ras4b precursor (2-aminobenzoyl-KSKTKC(farnesyl)-K(Dnp)-IM) Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B1benzyloxycarbonyl-Phe-Ala-2,4,6-trimethylbenzoyloxymethyl ketone 0.25 mM, 12% inhibition of cleavage of a quenched fluorogenic farnesylated peptide that is based on the C-terminal sequence of the K-Ras4b precursor (2-aminobenzoyl-KSKTKC(farnesyl)-K(Dnp)-IM) Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B1benzyloxycarbonyl-Phe-Ala-2,4,6-trimethylbenzoyloxymethyl ketone 0.25 mM, 10% inhibition of cleavage of a quenched fluorogenic farnesylated peptide that is based on the C-terminal sequence of the K-Ras4b precursor (2-aminobenzoyl-KSKTKC(farnesyl)-K(Dnp)-IM) Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.99.B1benzyloxycarbonyl-Phe-Lys-2,4,6-trimethylbenzoyloxymethyl ketone 0.25 mM, 61% inhibition of cleavage of a quenched fluorogenic farnesylated peptide that is based on the C-terminal sequence of the K-Ras4b precursor (2-aminobenzoyl-KSKTKC(farnesyl)-K(Dnp)-IM), inhibition is not readily reversible Go to the Ligand Summary Page
Results 1 - 10 of 43 > >>
download as CSV
download all results as CSV